Viewing Study NCT05429593


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-02 @ 11:13 PM
Study NCT ID: NCT05429593
Status: COMPLETED
Last Update Posted: 2024-08-07
First Post: 2022-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
Sponsor: Novo Nordisk A/S
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-06-22
Start Date Type: ACTUAL
Primary Completion Date: 2023-03-10
Primary Completion Date Type: ACTUAL
Completion Date: 2023-04-13
Completion Date Type: ACTUAL
First Submit Date: 2022-06-17
First Submit QC Date: None
Study First Post Date: 2022-06-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-06
Last Update Post Date: 2024-08-07
Last Update Post Date Type: ACTUAL